# CureVac

> mRNA medical technology development

Business model and tags: B2B, Has physical offices, Pharma & life sciences, Subsidiary, Multi-site, International operations, Has production sites, Has in-house R&D, Has a works council

## About CureVac

Global biopharmaceutical company specializing in mRNA technology to develop vaccines, cancer therapies, and rare disease treatments by instructing the body to produce proteins

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 251–1,000 employees
- **Headquarters**: Tübingen, Baden-Württemberg, Germany
- **Founded**: 2000
- **Revenue**: €535M (FY2024, publicly reported)
- **Website**: [curevac.com](https://www.curevac.com/curevac-is-now-part-of-the-biontech-group/)
- **LinkedIn**: [linkedin.com/company/curevac](https://www.linkedin.com/company/curevac)

## CureVac in the news

- [Tübinger Biotech-Unternehmen: Wie geht es für die Curevac-Mitarbeiter weiter?](https://www.swp.de/lokales/tuebingen/tuebinger-biotech-unternehmen-curevac-job-drehscheibe-im-haus-79717808.html) · swp.de · Nov 20, 2026
  CureVac is collaborating with the employment agency following a plant closure to assist its employees.
- [Tübinger Haushalt: Curevac spült Geld in die Stadtkasse](https://www.swp.de/lokales/tuebingen/tuebinger-haushalt-curevac-spuelt-geld-in-die-stadtkasse-79637172.html) · swp.de · Nov 6, 2026
  CureVac's commercial tax payments bolster Tübingen's municipal finances, though the city must share some revenue with other municipalities.
- [Ingmar Hoerr bei den Filmtagen: Curevac-Gründer fühlt sich von Biontech in die Irre geführt](https://www.frankenpost.de/inhalt.ingmar-hoerr-bei-den-filmtagen-curevac-gruender-fuehlt-sich-von-biontech-in-die-irre-gefuehrt.837693b1-36dd-41d0-bc10-1941d7e9750f.html) · frankenpost.de · Oct 23, 2026
  CureVac founder Ingmar Hoerr, a pioneer in mRNA technology, feels misled by BioNTech after his company faced setbacks during the pandemic.

[See all 20 articles](https://www.tamtam.ai/c/curevac/news)

## CureVac at a glance

CureVac is a B2B company in the Biotechnology Research industry, headquartered in Tübingen, Baden-Württemberg, Germany.

CureVac was founded in 2000.

CureVac has 251–1,000 employees.

CureVac's revenue is €535M (FY2024, publicly reported).

## Frequently asked questions about CureVac

### What is CureVac's revenue?

CureVac's revenue is €535M (FY2024, publicly reported).

### How many employees does CureVac have?

CureVac has 251–1,000 employees.

### Where is CureVac headquartered?

CureVac is headquartered in Tübingen, Baden-Württemberg, Germany.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/curevac
